153 related articles for article (PubMed ID: 11391624)
1. Deletion mapping of chromosome 16q24 in hepatocellular carcinoma in Taiwan and mutational analysis of the 17-beta-HSD gene localized to the region.
Lin YW; Lee IN; Chen CH; Huang GT; Lee HS; Lee PH; Lu FJ; Sheu JC
Int J Cancer; 2001 Jul; 93(1):74-9. PubMed ID: 11391624
[TBL] [Abstract][Full Text] [Related]
2. Mapping of the HSD17B2 gene encoding type II 17 beta-hydroxysteroid dehydrogenase close to D16S422 on chromosome 16q24.1-q24.2.
Durocher F; Morissette J; Labrie Y; Labrie F; Simard J
Genomics; 1995 Feb; 25(3):724-6. PubMed ID: 7759109
[TBL] [Abstract][Full Text] [Related]
3. Investigation in liver tissues and cell lines of the transcription of 13 genes mapping to the 16q24 region that are frequently deleted in hepatocellular carcinoma.
Riou P; Saffroy R; Comoy J; Gross-Goupil M; Thiéry JP; Emile JF; Azoulay D; Piatier-Tonneau D; Lemoine A; Debuire B
Clin Cancer Res; 2002 Oct; 8(10):3178-86. PubMed ID: 12374686
[TBL] [Abstract][Full Text] [Related]
4. Identification of a 1-Mb common region at 16q24.1-24.2 deleted in hepatocellular carcinoma.
Bando K; Nagai H; Matsumoto S; Koyama M; Kawamura N; Tajiri T; Onda M; Emi M
Genes Chromosomes Cancer; 2000 May; 28(1):38-44. PubMed ID: 10738301
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
[TBL] [Abstract][Full Text] [Related]
6. Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer.
Kawakami M; Staub J; Cliby W; Hartmann L; Smith DI; Shridhar V
Int J Oncol; 1999 Oct; 15(4):715-20. PubMed ID: 10493953
[TBL] [Abstract][Full Text] [Related]
7. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
[TBL] [Abstract][Full Text] [Related]
8. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
Yakicier MC; Legoix P; Vaury C; Gressin L; Tubacher E; Capron F; Bayer J; Degott C; Balabaud C; Zucman-Rossi J
Oncogene; 2001 Aug; 20(37):5232-8. PubMed ID: 11526514
[TBL] [Abstract][Full Text] [Related]
9. [Frequent loss of heterozygosity on chromosome 4 in human hepatocellular carcinoma].
Li X; Ding M; Lai B
Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):37-40. PubMed ID: 11798850
[TBL] [Abstract][Full Text] [Related]
10. Frequent allelic loss on chromosome 9 in hepatocellular carcinoma.
Liew CT; Li HM; Lo KW; Leow CK; Lau WY; Hin LY; Lim BK; Lai PB; Chan JY; Wang XQ; Wu S; Lee JC
Int J Cancer; 1999 May; 81(3):319-24. PubMed ID: 10209942
[TBL] [Abstract][Full Text] [Related]
11. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas].
Shao J; Li X; Liu Z
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
[TBL] [Abstract][Full Text] [Related]
13. Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region.
Fang W; Piao Z; Simon D; Sheu JC; Huang S
Genes Chromosomes Cancer; 2000 Jul; 28(3):269-75. PubMed ID: 10862032
[TBL] [Abstract][Full Text] [Related]
14. Deletion mapping of chromosome 16q in hepatocellular carcinoma.
Piao Z; Park C; Kim JJ; Kim H
Br J Cancer; 1999 May; 80(5-6):850-4. PubMed ID: 10360665
[TBL] [Abstract][Full Text] [Related]
15. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
[TBL] [Abstract][Full Text] [Related]
16. SIAH1 inactivation correlates with tumor progression in hepatocellular carcinomas.
Matsuo K; Satoh S; Okabe H; Nomura A; Maeda T; Yamaoka Y; Ikai I
Genes Chromosomes Cancer; 2003 Mar; 36(3):283-91. PubMed ID: 12557228
[TBL] [Abstract][Full Text] [Related]
17. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma.
Ko JY; Lee TC; Hsiao CF; Lin GL; Yen SH; Chen KY; Hsiung CA; Chen PJ; Hsu MM; Jou YS
Cancer; 2002 Apr; 94(7):1987-96. PubMed ID: 11932901
[TBL] [Abstract][Full Text] [Related]
18. Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma.
Saffroy R; Riou P; Soler G; Azoulay D; Emile JF; Debuire B; Lemoine A
Eur J Hum Genet; 2002 Apr; 10(4):239-44. PubMed ID: 12032731
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions.
Lin YW; Sheu JC; Liu LY; Chen CH; Lee HS; Huang GT; Wang JT; Lee PH; Lu FJ
Eur J Cancer; 1999 Nov; 35(12):1730-4. PubMed ID: 10674021
[TBL] [Abstract][Full Text] [Related]
20. Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan.
Chou YH; Chung KC; Jeng LB; Chen TC; Liaw YF
Cancer Lett; 1998 Jan; 123(1):1-6. PubMed ID: 9461010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
